Close
  Indian J Med Microbiol
 

Figure 3: Immunohistochemical results. (a) Case 4 (a-b): Diffuse vimentin positivity, including focal positivity in epithelium (arrow head) (diaminobenzidine × 200). (b) Estrogen receptor-positive glands (diaminobenzidine, × 400). (c) Case 7: Diff use progesterone receptor positivity in stroma. (diaminobenzidine × 400). (d) Case 15 (d-e): SMA positivity in stroma. Negative glands (arrow head) (diaminobenzidine, × 400). (e) Focal MIB1 positivity (diaminobenzidine, × 400). (f) Case 3: CD34 positivity. (g) Case 12 (g-h): Desmin-positive rhabdomyoblasts (diaminobenzidine, × 400). (h) Discrete myogenin positivity (diaminobenzidine, × 400)

Figure 3: Immunohistochemical results. (a) Case 4 (a-b): Diffuse vimentin positivity, including focal positivity in epithelium (arrow head) (diaminobenzidine × 200). (b) Estrogen receptor-positive glands (diaminobenzidine, × 400). (c) Case 7: Diff use progesterone receptor positivity in stroma. (diaminobenzidine × 400). (d) Case 15 (d-e): SMA positivity in stroma. Negative glands (arrow head) (diaminobenzidine, × 400). (e) Focal MIB1 positivity (diaminobenzidine, × 400). (f) Case 3: CD34 positivity. (g) Case 12 (g-h): Desmin-positive rhabdomyoblasts (diaminobenzidine, × 400). (h) Discrete myogenin positivity (diaminobenzidine, × 400)